Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women.
D Goodman-Gruen, D Kritz-Silverstein
https://pubmed.ncbi.nlm.nih.gov/11285326/Completed
Phase 2
Age: 45Years - 74Years
FEMALE
ID00000613
CVD Risk and Health in Postmenopausal Phytoestrogen Users
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-02-29
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
To determine the acceptability and benefits of use of a dietary supplement of the phytoestrogen, genistein, versus placebo on heart disease risk factors, bone density, and psychosocial outcomes in postmenopausal women.
CONDITIONS
Brief Title
CVD Risk and Health in Postmenopausal Phytoestrogen Users
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here